Invaio Sciences, Inc. recently announced a collaboration with Fundecitrus (Fund for Citrus Protection), a research organization based in Araraquara, Brazil. The partnership aims to accelerate the development and evaluation of novel solutions — particularly peptide-based technologies — for controlling huanglongbing (HLB), also known as citrus greening disease.
The collaboration combines Invaio’s Biologicals by Design™ platform and Fundecitrus’ expertise in grove and pest management.
The bacterium responsible for HLB — Candidatus Liberibacter asiaticus (CLas) — cannot be cultured in the laboratory. As a result, Fundecitrus has pioneered specialized assays and field-based methods to evaluate candidate solutions where traditional approaches fall short. By combining their complementary strengths, Invaio and Fundecitrus seek to overcome longstanding barriers in HLB research and accelerate progress toward practical, field-ready tools for growers.
“We’re thrilled to deepen our collaboration with Fundecitrus,” said Ricardo Miranda, vice president and head of global development at Invaio. “Their scientific leadership is critical to advancing new solutions that can transform the way this devastating disease is managed.”
Invaio will also deploy its precision delivery platform, Trecise™, to test and deliver promising candidates directly into citrus trees under real-world conditions.
“We are preparing to launch our first HLB solution in Brazil and are committed to expanding the arsenal of tools available to growers,” said Avram Slovic, head of the Latin American Division at Invaio Sciences. “Working with Fundecitrus — widely recognized as one of the world’s foremost authorities in citrus health — positions us to translate lab innovation into meaningful impact in the grove.”
Source: Invaio
Share this Post